14-day Premium Trial Subscription Try For FreeTry Free
Dr. Anthony Fauci told Insider, if he had to guess, Pfizer will conclude its trial in the coming months so a shot will reach under 5s in early 2022.

Pfizer Again, Macy''s, GlobalFoundries: 3 Things to Watch

08:47pm, Thursday, 18'th Nov 2021 Investing.com
https://www.investing.com/news/stock-market-news/pfizer-again-macys-globalfoundries-3-things-to-watch-2684551

Pfizer Inc. (NYSE:PFE) Shares Purchased by Veriti Management LLC

08:31pm, Thursday, 18'th Nov 2021 Transcript Daily
Veriti Management LLC raised its stake in shares of Pfizer Inc. (NYSE:PFE) by 7.6% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 28,324 shares of the biopharmaceutical companys stock after purchasing an additional 2,002 shares during the quarter. Veriti Management LLCs holdings in Pfizer were worth $1,218,000 at the end of the most recent []
Sask. public health is ready to roll on a youth vaccination plan, provided Health Canada approval for Pfizer comes through this week.

US Agrees With Pfizer to Buy 10M Courses of Its COVID Pill

08:05pm, Thursday, 18'th Nov 2021 Big News Network
U.S. President Joe Biden announced Thursday the U.S. has agreed to buy 10 million treatment courses of Pfizer''s new - and yet to be authorized - COVID-19 treatment pill beginning later this year and concluding in 2022. In a statement on the White House website, the president said his administration is taking steps to ensure these treatments will be easily accessible and free, once it is approved by the Food and D

Pfizer to sell 10 million COVID-19 treatments to US for $5.3 bn

08:00pm, Thursday, 18'th Nov 2021 Eyewitness News
Pfizer will start delivering the treatments to the US government later this year and continuing through the end of 2022, the statement said.
OTTAWA Canada will announce on Friday it is authorizing the use of Pfizer Incs COVID-19 vaccine in children aged between 5 and 11, a government source said on Thursday. The announcement will be made at 10 am Eastern time (1500 GMT), said the source, who requested anonymity because of the sensitivity of the situation. []
The National Immunisation Advisory Committee (NIAC) has recommended that People who received the Johnson and Johnson Covid-19 vaccine should receive a booster vaccine three months after vaccination. Boosters for anyone who received the Pfizer, Moderna or AstraZeneca vaccine are to be delivered following a minimum interval of five months. A total of 236,313 people received []

Alberta premier defends plan to not make vaccines mandatory in schools

07:42pm, Thursday, 18'th Nov 2021 City News Calgary
Alberta Premier Jason Kenney is defending his governments plan to not make it mandatory for kids in Kindergarten to Grade 12 to have their COVID-19 vaccine if they want to go to class. It comes a day before Health Canada could approve Pfizers vaccine for children aged 5 to 11. RELATED: Health Canada to approve [] The post Alberta premier defends plan to not make vaccines mandatory in schools appeared first on CityNews Calgary .

More People Died in the Key Clinical Trial for Pfizers COVID Vaccine than the Company Publicly Reported

07:25pm, Thursday, 18'th Nov 2021 The Centre for Research on Globalization (CRG)
All Global Research articles can be read in 51 languages by activating the Translate Website drop down menu on the top banner of our home page (Desktop version). To receive Global Researchs Daily Newsletter (selected articles), click here . Visit The post More People Died in the Key Clinical Trial for Pfizers COVID Vaccine than the Company Publicly Reported appeared first on Global Research .

Rede Wealth LLC Invests $203,000 in Pfizer Inc. (NYSE:PFE)

07:16pm, Thursday, 18'th Nov 2021 Dakota Financial News
Rede Wealth LLC acquired a new position in shares of Pfizer Inc. (NYSE:PFE) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 4,725 shares of the biopharmaceutical companys stock, valued at approximately $203,000. Other hedge funds have also modified their holdings []
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the European Commission has approved XELJANZ® (tofacitinib) 5 mg twice daily for the treatment of adults with active ankylosing spondylitis (AS) who have responded inadequately to conventional therapy. XELJANZ is the first and only oral Janus kinase (JAK) inhibitor approved for five indications in the European Union (EU), including in adults with moderate to severe active rheumatoid arthritis (RA), adults with active psoria
President Joe Biden on Thursday announced the United States is buying 10 million courses of Pfizer''s Covid-19 treatment pill, in a $5.3 billion deal he touted as "critical" to fighting the pandemic.

Pfizer, US gov sign $5 billion deal for possible COVID-19 treatment

06:16pm, Thursday, 18'th Nov 2021 New York Post
Pfizer asked the FDA on Tuesday to authorize emergency use of the experimental pill, which has been shown to significantly cut the rate of hospitalizations and deaths
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE